ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0061333;renal tubule morphogenesis;6.0;0.7192862368539868;0.682763431017138;8.801845679307654;32.20947323359611;6.943860283624253;0.0010780220824845236;0.6782296504172152;[MEF2C, COL4A1, TACSTD2, LGR4]
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[HMGB2, LRP2, GATA3, MEA1, HOXA11, HOXA10, PDGFRB, LHCGR, TGFB2, BIK, INHBA, EIF2S2, SFRP2, NASP, MSH2, KIT]
GO:0014065;phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;26.42836680105094;6.343086423195323;8.845336528452411E-4;0.6993857346658935;[GATA3, AKT1]
GO:0035162;embryonic hemopoiesis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;36.11381869205153;6.832634648514029;0.0012086970112962418;0.6725415662651573;[FLT3LG, GATA3, KIT]
GO:1902036;regulation of hematopoietic stem cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;97.61516402498306;6.558197802812269;0.003267091691972132;0.6863059058804069;[GATA3, MYB]
GO:0002003;angiotensin maturation;8.0;1.0;0.875;9.628524252492122;184.72117518317427;7.379178354882098;0.00618245149511628;0.7523715242355574;[ENPEP, ACE, MME, CTSG]
GO:0071493;cellular response to UV-B;8.0;1.0;0.875;9.628524252492122;82.44278777713699;7.697632086000634;0.0027592859132088378;0.7686572628545723;[MFAP4, CDKN1A, MME]
GO:0002634;regulation of germinal center formation;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;44.47967864407596;7.57984905034425;0.0014886948151053528;0.738553198190834;[MEF2C, BCL6, TNFAIP3, PKN1, TNFSF13B]
GO:0071492;cellular response to UV-A;8.0;1.0;0.875;9.628524252492122;82.44278777713699;8.67846133901236;0.0027592859132088378;0.8188169164668168;[MME]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[EHMT2, SLA2, PHB2, MYB, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, PRDM16, ELANE, JUN, PKIG, EZH2, PAWR, PAX5, SIRT1, PAX2, AES, MMP12, BTAF1, FLNA, NR1H2, LGR4, GMNN, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, EMILIN1, RFC1, XCL1, RBBP8, E2F7, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, DPF3, RUNX2, SFRP2, PCBP3, EGR1, BCL11A, IFNA2, PTPRK, XPO1, CD36, MDFIC, IL1B, ARID4A, CHCHD3, BASP1, CCNE1, CALCA, TGFB1, CBX4, CAV1, HMGA1, NR4A2, MXD1, CREBZF, HMGB2, MYOCD, IFNG, ELF3, FBP1, PFDN5, MEIS2]
GO:0071498;cellular response to fluid shear stress;4.0;0.7980440201809971;0.6490220100904985;9.271849308553389;39.92524609926753;6.8867018697843045;0.0013362620565537933;0.6021862538851576;[MEF2C, PTGS2]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[TPM1, MSH2, GATA3, EPB41L5, PLCG1, EIF2S2, MAFF, PTPRR, TMEM100, HHEX, TIE1]
GO:0071773;cellular response to BMP stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.280566066213989;0.003262744749111514;0.6443087532925187;[TMEM100, SPINT1, SPINT2, GATA3, ADAMTS12, RUNX2]
GO:0071374;cellular response to parathyroid hormone stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;109.38485831558611;7.57984905034425;0.003661012767841448;0.710754145523778;[MEF2C]
GO:0072107;positive regulation of ureteric bud formation;8.0;0.8933024483968273;0.8216512241984136;9.541512875502493;494.4706120919299;8.390779266560578;0.01654948639205751;0.8041048419030481;[GATA3]
GO:0001947;heart looping;7.0;1.0;0.8509193652572005;9.628524252492122;47.98143023837329;5.71663061713405;0.001605895289594654;0.6432681208679463;[DLL1, MEF2C, ENG]
GO:2000111;positive regulation of macrophage apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;256.05226485460065;8.67846133901236;0.008569838872606032;0.8400575416471059;[MEF2C, SIRT1]
GO:2000352;negative regulation of endothelial cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.9263443150347;6.444869117505266;0.0043485178181058145;0.7258315315665724;[TNFAIP3, GATA3, TEK]
GO:0070207;protein homotrimerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;6.444869117505266;0.002859955186148837;0.6805102716434839;[ARG1, MGST1, MIF, TCL1A, EMILIN1, CD247]
GO:0050435;amyloid-beta metabolic process;6.0;0.9326813400603323;0.7894609826203107;9.533214072687796;60.01596331221528;6.943860283624253;0.0020086802811995464;0.6782296504172152;[ACE, MME, PSEN2, APEH]
GO:0032689;negative regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.343086423195323;0.002184000309729388;0.647506047256038;[CD274, CD96, LILRB1, INHBA, PDCD1LG2, GATA3, XCL1, TLR4, HAVCR2]
GO:0050679;positive regulation of epithelial cell proliferation;6.0;0.7192862368539868;0.682763431017138;8.647694999480395;65.06748660449396;4.584116776790259;0.002177750219716307;0.5575522577384293;[NRP1, NRP2, ITGB3, HMGB2, TNFAIP3, LAMC1, CDH3, AKT1, GHSR, ARG1, SIRT1, PAX2, MMP12, AGTR1, C5AR1, TGFA, IQGAP3, CCL5, PLCG1, JUN, TGFB1, EGR3, CAV2, TNFSF12, LAMB1, NR4A1, LRG1, CXCL12, TEK]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, TNF, TCL1A, AKT1, IFNA14, IFNA16, MIF, SFRP2, IFNG, IFNA10, PTGS2, PAK1, NTF3, IFNA21, TGFB1, CAV1]
GO:0060231;mesenchymal to epithelial transition;5.0;0.8259837884571596;0.7032329060895001;9.34084218004034;24.20171999872632;7.004484905440688;8.100097882234571E-4;0.6484506956670166;[BASP1, GATA3, PAX2]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[, NUP107, PRKACB, CLDN3, PADI4, PDGFC, ABCA1, JUP, COL1A1, HLA-DRB1, ARHGAP6, CHAF1B, CHAF1A, KCND2, ARG1, F5, SLC7A7, KCNA5, HLA-DMA, HLA-DMB, DMD, CENPK, CENPL, GOPC, KCNG2, GMNN, RUVBL2, RUVBL1, OLFM4, BLM, UQCRB, LIN7A, CXCL12, HLA-DRA, LRRK2, ALAD, VBP1, NDUFC2, ACPP, BDP1, NDUFB7, NDUFB6, HM13, NDUFB4, NDUFB3, NDUFB2, NDUFB1, CCL5, EIF4H, NDUFA8, NDUFA7, NDUFA6, NDUFA3, NDUFA2, IL2RB, CD247, EIF3D, CCNH, TCL1A, SNRPD2, SNRPD1, TNFSF11, FBXO5, SNRPD3, MIF, TGFA, PTK2, CD3G, CD3E, CD3D, CCT3, CCT2, FCER1G, MIS12, CCT8, GCH1, RPA1, RPA3, NDUFAB1, NDUFB10, NDUFB11, H1FX, CAV2, CAV1, HMGA1, NASP, TCF4, HMGB2, TNFAIP3, LAMC1, NUP62, NDUFS8, NDUFS7, NDUFS6, NDUFS4, NDUFS3, NUP54, FBP1, TAF9, SAMHD1, EGF, TTC19, TEK, CDA, BIN2, NUP205, ACMSD, NCKAP1L, SERPINA1, BRD2, GSN, GTF2H1, TNF, DACH1, MEN1, TLE4, SNRPG, SNRPE, SNRPF, NACC2, LSM3, HOPX, EMILIN1, ADSL, VWF, TRAF1, PTBP2, MCM2, NLGN1, NLRC4, PLN, WASF3, RAD51, P2RX1, IMPDH2, PPP2R1A, MCCC2, COX7A2L, TLN1, MGST1, CD79B, CD79A, VASP, AHCTF1, RAD51C, UQCR10, NDUFA11, KNTC1, CHRNB4, ADRB2, NLRP3, MYH11, TGFB1, EIF2S1, AXIN2, DNM2, TGFBR3, COLEC12, HIST1H2BK, HSPD1, REPS2, RBMX]
GO:0007264;small GTPase mediated signal transduction;6.0;0.7369933605727446;0.6916169928765168;8.741221057491218;26.42836680105094;4.015022244900292;8.845336528452411E-4;0.5284487369119741;[CYFIP1, CELSR1, EPS8, GRAP2, ARHGDIA, ARHGDIB, RAB32, DOK3, AGTR1, IQGAP3, RASGRP4, JUN, HACE1, PLK2, DHCR24, ARHGAP30, BCL6, RGL4, RGL1, LAT, DOCK5, CDKN1A, ARHGAP6, ARHGAP4, RAC2, RALGPS2, CHUK, RHOG, RHOH, VAV1, RAB33B, RHOU, RAB21, PAK1, PDPN, EPS8L1, DNAJA3]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[TNFAIP6, TNFAIP3, CDH5, DUSP10, GHSR, IL1R2, TNFRSF1B, CALCRL, GATA3, NT5E, NLRP3, ELANE, NFKB1, NLRP12, TEK, FCGR2B]
GO:0060998;regulation of dendritic spine development;10.0;0.8259837884571596;0.8282329060895002;9.517298617381897;87.62706980140223;5.572381008289503;0.002932799167010087;0.7002128357670632;[NLGN1, LRRK2, FMR1, MEF2C, PLK2]
GO:0045652;regulation of megakaryocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.9575807315309;5.845247994956144;0.0023079481692908138;0.6498456195510879;[ITGA2B, HMGB2, THBS1, NFE2, MEF2C, GP1BA, PRKCQ, MYL9, PF4]
GO:0042421;norepinephrine biosynthetic process;8.0;1.0;0.875;9.628524252492122;472.6140365713203;7.9853141584524145;0.015817966479023615;0.7833693374183408;[GATA3]
GO:0072182;regulation of nephron tubule epithelial cell differentiation;7.0;0.811012628672052;0.7564256795932265;9.387362195675234;88.9858058127024;7.212124270218933;0.002978274838525283;0.7197477358342742;[GATA3, CD24, PAX2]
GO:0072178;nephric duct morphogenesis;6.0;0.8653626801206646;0.7558016526504768;9.377209824211215;32.20947323359611;7.57984905034425;0.0010780220824845236;0.710754145523778;[GATA3]
GO:0061290;canonical Wnt signaling pathway involved in metanephric kidney development;9.0;0.9326813400603323;0.8625812952104552;9.567899630675686;106.74416304630388;9.083926447120524;0.0035726310736500203;0.8607930461318132;[GATA3, LGR4]
GO:0014902;myotube differentiation;6.0;0.8653626801206646;0.7558016526504768;9.377209824211215;22.452520143917486;7.379178354882098;7.514656432606705E-4;0.7004918368257019;[MEF2C, SORT1, AVPR1A]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, TFRC, TNFSF13B, NCKAP1L, MEF2C, FCRL3, MIF, MSH6, BST1, PTPRC, BCL6, CARD11, CD320]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CD80, TNF, FGF5, TNFSF11, CCR7, PDGFRB, GAB1, VAV1, BTC, LCK, KIT, CHI3L1, HBEGF, ENG, GATA3, THBS1, CD19, FYN, CCL19, ICOS, TGFB1, TRAT1, EGF, PTK2, LIN28A, CD28, NOX4, TEK]
GO:1905563;negative regulation of vascular endothelial cell proliferation;8.0;1.0;0.875;9.628524252492122;108.34661668819432;8.390779266560578;0.0036262637549294456;0.8041048419030481;[MEF2C, CCL2]
GO:0060025;regulation of synaptic activity;7.0;1.0;0.8509193652572005;9.628524252492122;30.61939422688933;8.67846133901236;0.001024803569108247;0.7947362817240173;[MEF2C]
GO:1904753;negative regulation of vascular associated smooth muscle cell migration;9.0;1.0;0.896240625180289;9.628524252492122;245.4091710939714;7.9853141584524145;0.008213624102600289;0.8046099625986299;[MEF2C, MYOCD, TPM1]
GO:0090399;replicative senescence;4.0;1.0;0.75;9.628524252492122;26.138269705024182;7.212124270218933;8.748243641116619E-4;0.6188283705770736;[CDKN1A, MME, CHEK1]
GO:0031581;hemidesmosome assembly;6.0;1.0;0.8231203125901445;9.628524252492122;36.796901128588246;7.292166977892469;0.0012315591657128446;0.6960420709600095;[CD151, LAMB3, ITGB4, LAMA3, LAMC2, LAMC1]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MEF2C, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, IQGAP3, PDGFD, PDGFC, NCKAP1L, PLCG1, ELANE, LYN, JUN, CDC6, CDKN1A, TIMP1, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, SIRT1, PAX2, MMP12, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, F2R, MSH6, CD274, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, BCL6, ITGB3, FASLG, TNFSF13B, LBH, XCL1, CX3CR1, SMARCD3, LRP2, CCL5, CTHRC1, KLF5, DNAJA3, PTPN6, TCL1A, EDNRB, SKP2, ICOSLG, FLT3LG, MIF, RUNX2, BTC, SFRP2, TGFA, PKHD1, EGR1, EGR3, TNFSF12, PTK2, BST1, CD28, CD24, CD320, NRP1, NRP2, PRL, CD3E, ESM1, RAC2, CTSH, CCR2, SYK, RHOG, PDCD1LG2, AVPR1A, HCK, CEACAM6, IL1B, KIT, GNAI2, PAK1, CXCR2, LILRB2, CD40LG, CD86, CD80, SIRPG, MPL, IL6R, PDGFRB, GHSR, CCNE1, PRTN3, CARD11, C5AR1, LTBP3, DPP4, TGFB2, TGFB1, CAV2, NR4A1, LIN28A, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, GLP2R, MMP9, TGFBR3, ZAP70, IFNG, NDUFS4, LTF, DLL1, THBS1, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, TEK]
GO:0002062;chondrocyte differentiation;4.0;0.8933024483968273;0.6966512241984136;9.446202695698167;21.066225782797595;6.039404009397101;7.050676185779127E-4;0.5588554019015759;[MEF2C, TGFB1, AXIN2, MAPK14, RUNX2]
GO:0045786;negative regulation of cell cycle;5.0;0.5089359064165209;0.5447089650691808;7.0970975870692286;42.34575940812408;3.5270983854209863;0.0014172744586806725;0.47061698731819834;[EHMT2, SMC3, UXT, CHEK1, FBXO5, PRKACB, MIF, AURKAIP1, GATA3, TP53BP2, SFN, BARD1, PLK2, CDC6, ZWINT, STAG2, EZH2, CDKN1A, PTPRK, BRCA2, DUSP1, PCNA, PTGS2, GPNMB, CDKN2C, LILRB1, SIPA1, GMNN, TNF, KNTC1, MEN1, MSH6, MSH2, BLM, CUL5, NACC2, NAE1, GAS2L1, MAP2K6, TGFB2, TGFB1, DHCR24, INHBA, NR4A1, BCL6, CNOT3, JMY, TNFAIP3, HHEX, TOPBP1, MYOCD, SMC1A, IFNG, THBS1, RBBP8, CCL2, BUB1, E2F7, MAPK14, WEE1, RAD51]
GO:0045666;positive regulation of neuron differentiation;8.0;0.6181399273706679;0.684069963685334;8.712233520617966;337.32148776029015;3.9481280100702625;0.011289846625707336;0.576907450041722;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, MEF2C, EPHA3, LYN, SYT2, CXCL12, LIN28A, BCL6, TCF4, EZH2, ROBO2, NRP1, NLGN1, RAB21, PAK1, CNR1, FYN]
GO:0002063;chondrocyte development;4.0;0.8933024483968273;0.6966512241984136;9.474373572664863;32.15320660831846;6.943860283624253;0.001076138889173156;0.6051093378270707;[SFRP2, COL11A1, RUNX2, SULF2]
GO:0045663;positive regulation of myoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;6.7325511899570465;0.00382428925936973;0.6674232935401965;[MEF2C, CXCL9, TNFSF14, FLT3LG, MAPK14]
GO:0042035;regulation of cytokine biosynthetic process;6.0;0.5280135766324326;0.5871271009063608;7.803974960441076;134.5037225521282;5.212725436212633;0.004501718548328373;0.5896993338145817;[CD86, CD80, CD3E, TNF, CCR2, GHSR, LAG3, SYK, TLR1, IL1B, TLR8, TLR7, PRKCQ, TLR6, TLR4, CARD11, PTAFR, GATA3, THBS1, INPP5D, ELANE, EGR1, CCL20, CARD9, PRG2, LILRB1, INHBA, AZU1, NFKB1, CD4, NLRP12, CD28]
GO:0022900;electron transport chain;4.0;0.7140352122741334;0.6070176061370667;8.475844742553736;29.758801740447502;4.623782033182691;9.96000313069993E-4;0.48646042820481683;[COX6A1, COX6B1, POR, COX7A2L, UQCRC1, NDUFB10, UQCRB, UQCRH, CYC1, UQCRQ, P4HA2, NOX4, COX7B, ETFA, COX7C, UQCRFS1, COX8A, NDUFC2, NDUFS8, NDUFS7, NDUFS6, NDUFS4, NDUFS3, NDUFB7, NDUFB6, NDUFB4, NDUFB3, NDUFB2, NDUFB1, UQCR10, COX5B, COX5A, NDUFA8, NDUFA7, NDUFA6, NDUFA4, NDUFA3, NDUFA2, COX6C, NDUFAB1]
GO:1901522;positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus;12.0;0.7140352122741334;0.8051379187272112;9.260799472366804;1467.8987330058965;6.641579411751319;0.04912924957061573;0.7877709925721352;[RUNX2]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[IL6R, CTHRC1, MEF2C, JAG1, RUNX2, SFRP2, LTF]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPIB, MYB, HOXA3, AKT1, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NKX2-3, JUN, JAG1, JUP, FZD5, PAX5, FOS, SIRT1, PAX2, MMP12, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, PSMC6, PSMC2, PF4, CCNT2, PLXND1, TNF, RUVBL2, MEN1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, CIITA, HHEX, PPP1R12A, CHUK, CEBPE, ABLIM3, E2F5, E2F7, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SLC11A1, EBF1, FLT3LG, RUNX2, SFRP2, BEX1, NHLH2, EGR1, EGR2, EGR3, BCL11B, CD28, PRL, CD3D, RGMA, IL1B, TLR4, TLR2, LILRB1, GRHL2, IL17A, ARID4A, ARID4B, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, CKAP2, DCN, ELF3, TAF9, DLL1, MAPK14, MEIS2, MEIS1, RBMX]
GO:0043523;regulation of neuron apoptotic process;7.0;0.7043150770688792;0.7030769037916401;8.763526815005518;34.538657273781794;4.5143834387755835;0.0011559777761799947;0.581785144256483;[MYB, MEF2C, F2R, MSH2, NAIP, C5AR1, GATA3, SLC30A10, CORO1A, NAE1, JUN, TGFB2, WFS1, NR4A2, UBE2M, NRP1, FASLG, CHL1, IL1B, LRP1, NTF3, CCL2, FYN, GABRA5]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, CHL1, MEF2C, F2R, MSH2, NAIP, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, FYN, JUN, WFS1, GABRA5, NR4A2]
GO:0048538;thymus development;5.0;1.0;0.7902410118609202;9.628524252492122;35.890675140737365;6.039404009397101;0.0012012285974499148;0.5990964137624962;[SLC46A2, GATA3, HOXA3, BCL11B]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[IL5RA, TNF, FGF5, TNFSF11, MEN1, PDGFRB, MEF2A, MEF2C, MAP2K2, PAQR3, BTC, CSF2RB, IQGAP3, RASGRP4, SPTA1, MAP2K6, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, MAP4K1, CHUK, DUSP6, IL1B, KIT, HBEGF, IL2RG, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, IL2RB, TEK]
GO:0010918;positive regulation of mitochondrial membrane potential;5.0;1.0;0.7902410118609202;9.628524252492122;24.658349685322438;7.57984905034425;8.252927728937918E-4;0.6778748447945537;[TCL1A, AKT1]
GO:0051145;smooth muscle cell differentiation;5.0;0.7763722522362496;0.6784271379790451;8.85533436425864;21.75937296335754;6.7325511899570465;7.282666309192915E-4;0.6345439928109722;[MEF2C, MYOCD, EDNRB]
GO:0043370;regulation of CD4-positive, alpha-beta T cell differentiation;10.0;0.6913464685778243;0.7609142461498325;9.292052015870908;204.09489559372972;5.970411137910149;0.006830872482041192;0.7205681151061569;[CD86, CD83, CD80, GATA3, MYB, NLRP3, NCKAP1L, CCL19, IL12RB1, ANXA1, BCL6, IFNG]
GO:0032703;negative regulation of interleukin-2 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.7325511899570465;0.002184000309729388;0.6674232935401965;[LAG3, XCL1, TNFAIP3, GATA3, HAVCR2]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[CPNE8, NLGN1, CPNE5, PHB2, KCNH1, MEF2A, MEF2C, JUN, FOS, TUBG1]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, FPR1, GATA3, FLRT2, HLA-DQA1, HLA-DRB4, HLA-DRB1, CDKN1A, LRRC4, TIMP1, HLA-DPA1, ANXA1, FOS, SIRT1, FCER2, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL20, HLA-DPB1, PF4, CSF3R, F13A1, IL5RA, CXCL13, TNF, PYCARD, IGHG1, IL13RA2, IFNA14, IFNA16, IFNA10, TNFRSF11A, FOXO1, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, FASLG, TNFSF13B, CHUK, TNFRSF1B, XCL1, CX3CR1, IL2RG, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1B, IL2RB, PTPN6, TNFSF11, ACSL1, IL1R1, IL1R2, FLT3LG, MIF, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, PPBP, SDC1, IFNA5, IFNA4, IFNA7, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, SYK, GP1BA, IL17RB, VAV1, HCK, CEACAM1, IL1B, KIT, RHOU, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, TGFB1, NFKBIA, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, GHR, LRRTM4, IRAK3, MMP9, DCN, IFNG, SAMHD1, NCAM1, CD4, LTBR]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[TNC, FBL, AKT1, MEF2C, TPM4, RUNX2, HSD17B4, GPNMB, FIGNL1, HSPE1, COL1A1, PSMC2, ALPL, RBMX, LGR4]
GO:0034446;substrate adhesion-dependent cell spreading;6.0;1.0;0.8231203125901445;9.628524252492122;56.23121614310476;6.088194173566533;0.0018820081995007299;0.63447084575632;[NRP1, ITGB3, LAMB1, LAMC1, TEK]
GO:0001806;type IV hypersensitivity;8.0;1.0;0.875;9.628524252492122;76.14798307094021;9.777073627680469;0.0025486044646488674;0.875;[GATA3]
GO:0072643;interferon-gamma secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;7.8311634786251565;0.004587596526932657;0.8157270763441555;[LILRB1, GATA3]
GO:0010595;positive regulation of endothelial cell migration;9.0;0.8259837884571596;0.8092325194088689;9.488762310116963;298.6320589889849;5.2552850506314295;0.009994946262957053;0.664996147065328;[NRP1, NRP2, ITGB3, AKT1, ANXA1, ANXA3, SIRT1, GATA3, PTGS2, THBS1, PLCG1, TGFB1, PLK2, TEK]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, TRAC, CD3G, PTPN22, CD3E, CD3D, GRAP2, TRBC1, PDE4B, ICOSLG, HLA-DPA1, CHUK, THEMIS, LIME1, ZAP70, LCK, BTK, PRKCQ, LCP2, CARD11, HLA-DQB1, HHLA2, GATA3, PAK1, INPP5D, FYN, CSK, PLCG1, HLA-DQA1, PAG1, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, PTPRC, CD28, HLA-DPB1, HLA-DRA, CD247, LAT, HLA-DRB1]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[, BLK, IGHM, ITK, CD79B, CD79A, IGHG1, IGKC, CD19, TRBC1, CTLA4, NCKAP1L, IGHA1, LYN, MEF2C, SYK, BMX, LIME1, LAT2, PTPRC, LCK, BTK, IGHD, PTPN6, MNDA]
GO:0035898;parathyroid hormone secretion;9.0;1.0;0.896240625180289;9.628524252492122;52.61642648053991;9.777073627680469;0.0017610244425941715;0.896240625180289;[GATA3]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[RUVBL1, SKP2, CFTR, PSMD14, ADRB2, GATA3, NLRP3, BARD1, NFKBIA, COPS5, TNFAIP3, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, FAM105A, USP9Y, PSMC6, PSMC2, EIF3F]
GO:0060374;mast cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;47.07409398820286;8.67846133901236;0.0015755275618510598;0.7669372290569613;[KIT, GATA3]
GO:0043537;negative regulation of blood vessel endothelial cell migration;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;356.3539069568923;6.311337724880743;0.01192684456815238;0.7380031166185408;[MEF2C, TGFB1, JUP, THBS1]
GO:0046928;regulation of neurotransmitter secretion;7.0;0.6493065804076676;0.6755726554610344;8.817594036275793;103.1091377978561;5.71663061713405;0.0034509700498948056;0.6432681208679463;[NLGN1, MCTP1, LRRK2, FMR1, MEF2C, CHRNB4, KMO]
GO:0022617;extracellular matrix disassembly;5.0;0.8653626801206646;0.7229223519212526;9.377209824211215;37.09213040667776;5.69953618377475;0.0012414402239614005;0.581715557354699;[LAMC1, MMP8, MMP9, CTSS, MMP12, CTSG, TIMP1, ELANE]
GO:0060536;cartilage morphogenesis;4.0;0.8436909121759173;0.6718454560879586;9.158520623246385;27.732136419115502;6.481236761676141;9.281696486453839E-4;0.5814507494004503;[MEF2C, COL14A1, COL12A1, COL6A3, HOXA5]
GO:0048701;embryonic cranial skeleton morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;46.18089108149027;6.280566066213989;0.0015456328643938164;0.6443087532925187;[PAX5, GRHL2, RUNX2]
GO:0048667;cell morphogenesis involved in neuron differentiation;6.0;0.811012628672052;0.7286266269261705;9.223059144383958;47.452274261266446;7.212124270218933;0.0015881849152503491;0.6919486831672181;[MEF2C, SLITRK6, SLC1A3]
GO:0048666;neuron development;4.0;0.6696747006330769;0.5848373503165385;8.088079211544972;32.15320660831846;4.814228997420562;0.001076138889173156;0.4961998948126311;[ROBO2, GABRB1, FMR1, MEF2C, TGFB2, GABRA5, SLC4A7, UQCRQ]
GO:0002076;osteoblast development;4.0;1.0;0.75;9.628524252492122;32.15320660831846;6.832634648514029;0.001076138889173156;0.5994212536750128;[CLEC5A, RUNX2, MEN1]
GO:1901536;negative regulation of DNA demethylation;8.0;1.0;0.875;9.628524252492122;378.9254775042988;8.67846133901236;0.012682294721279422;0.8188169164668168;[GATA3]
GO:0001782;B cell homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;22.00128503895464;6.599019797332524;7.363632103827933E-4;0.6883935445785896;[LYN, MEF2C, TNFRSF13B, TNFAIP3, TNFSF13B, NCKAP1L, PKN1]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[TAGLN, SGCE, BASP1, DMD, MEF2A, MEF2C, EGR3, SIRT1, CXCL10, ITGA7, COL6A3, HBEGF]
GO:0002467;germinal center formation;5.0;1.0;0.7902410118609202;9.628524252492122;29.459500770284833;7.697632086000634;9.859829789520339E-4;0.6838982747154925;[MEF2C, BCL6, CXCL13]
GO:2000703;negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation;9.0;1.0;0.896240625180289;9.628524252492122;864.3298087113885;9.777073627680469;0.028928340851244395;0.896240625180289;[GATA3]
GO:2000146;negative regulation of cell motility;6.0;0.5781283279524737;0.6121844765663813;8.01908634005802;116.39406446339459;4.247644540169047;0.0038956045897326065;0.5403450519100613;[SPINT2, CXCL13, DACH1, ARHGDIB, HOXA7, MEF2C, TPM1, MIF, SFRP2, PADI2, VCL, TACSTD2, GATA3, KLRK1, STAP1, TGFB1, JAG1, JUP, CXCL12, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, TMEFF2, ENG, CX3CR1, LRP1, THBS1, SPOCK3, CCL2, TIE1, PODN]
GO:2000664;positive regulation of interleukin-5 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.5029195149353;7.9853141584524145;0.02521906460756386;0.8236103492792612;[GATA3, IL17RB]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[CSF3R, PROS1, SIRPG, CXCL13, CXCL16, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, PRTN3, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, NUP85, INPP5D, IGLV1-44, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, CXCL10, CXCL11, SDC1, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, CXCL1, SLC7A11, CXCL3, CXCL2, TREM1, CXCL5, PDE4B, OLR1, FFAR2, CCR7, CCR6, CCR5, CCR2, ANXA1, FCER1G, SYK, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, IL1B, KIT, PECAM1, XCL1, CX3CR1, CCL13, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CCL23, CCL20, CD2, NLRP12, PTPN6, TEK, CD244, PF4]
GO:2000667;positive regulation of interleukin-13 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.5029195149353;7.9853141584524145;0.02521906460756386;0.8236103492792612;[GATA3, IL17RB]
GO:0018401;peptidyl-proline hydroxylation to 4-hydroxy-L-proline;10.0;1.0;0.9152410118609203;9.628524252492122;440.6873543070796;7.697632086000634;0.014749409155788068;0.8088982747154926;[P4HA2]
GO:0060045;positive regulation of cardiac muscle cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;720.414482973016;6.641579411751319;0.024111624414165377;0.7548916918429109;[TGFBR3, MEF2C, MAPK14]
GO:0040036;regulation of fibroblast growth factor receptor signaling pathway;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;67.94038154209638;6.375876246018314;0.002273903427840277;0.6491829203200885;[GATA3, THBS1, RUNX2, DUSP6, SULF2]
GO:0055012;ventricular cardiac muscle cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;47.302935560632505;8.16763571524637;0.001583186683336236;0.7686126355688037;[MEF2C, MYOCD]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, CCNH, SPIB, MYB, HOXA7, HOXA5, MEF2A, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NHLH2, EGR1, EGR2, JUN, BCL11B, TGFB1I1, PAX5, FOS, SIRT1, PAX2, FLNA, GTF2H1, GRHL2, CCNT2, ARID4A, HOXA10, C5AR1, HMGA1, NFKB1, COPS5, MAFF, MYOCD, ELF3, CREB5, CEBPE, TAF9, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, MEIS2, MEIS1, KLF5, POU2AF1, RBMX]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CCNH, NR3C2, CTGF, NRBP1, RUNX2, MAZ, NR4A2, NR4A1, TCF4, CDKN1A, MED23, TAF9, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, NR1H2, GTF2H1]
GO:0035914;skeletal muscle cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.845247994956144;7.050676185779127E-4;0.5489262542938873;[EGR1, MEF2C, EGR2, PAX5, FOS, KLF5, MAFF, ATF3]
GO:2000679;positive regulation of transcription regulatory region DNA binding;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;47.96814533750694;6.641579411751319;0.0016054506559182917;0.6627709925721352;[TGFB1, IFNG, GATA3]
GO:0030509;BMP signaling pathway;11.0;0.7090535922965819;0.7869557484779532;9.133828010656014;282.55034729266697;5.202362649177086;0.009456705845082177;0.6984780201431826;[TMEM100, EGR1, TGFB2, TGFB1, USP9Y, RUNX2, RGMA, TGFBR3, ENG]
GO:0048167;regulation of synaptic plasticity;7.0;0.6729672293956388;0.6874029799550199;8.567652291806858;39.259689615435484;4.623782033182691;0.0013139864800018823;0.5873797934620173;[MCTP1, FMR1, NRGN, GRM5, TNR, MEF2C, SORCS3, KIT, CX3CR1, SLC24A2, SLC24A1, NLGN1, PTGS2, EGR2, PLK2, LILRB2]
GO:0030220;platelet formation;5.0;1.0;0.7902410118609202;9.628524252492122;33.79744107268718;6.832634648514029;0.0011311699369806302;0.639662265535933;[MEF2C, ACTN1, NBEAL2, PTPN6]
GO:2000311;regulation of AMPA receptor activity;9.0;0.8933024483968273;0.8428918493787028;9.541512875502493;200.74624271324296;6.558197802812269;0.006718796083723233;0.7316271658034954;[MEF2C, NLGN1, ADRB2]
GO:2000310;regulation of NMDA receptor activity;9.0;0.8933024483968273;0.8428918493787028;9.541512875502493;200.74624271324296;6.8867018697843045;0.006718796083723233;0.7484268790654467;[MEF2C, NLGN1]
GO:0010975;regulation of neuron projection development;8.0;0.5673924682959377;0.6586962341479689;8.404748820870006;84.29486529122617;3.652390236786265;0.0028212732808438556;0.5617834065627654;[CYFIP1, CPNE5, AKT1, MEF2C, PAQR3, SFRP2, EPHA3, SDC2, GATA3, LYN, PLK2, PTK2, EZH2, ITM2C, ROBO2, NRP1, ARHGAP4, RGMA, PAK1, SCARB2, SEMA5B, PLXND1, FMR1, ARHGDIA, TNR, SYT2, CXCL12, LRRK2, DCC, DNM2, NLGN1, LRP1, RAB21, CNR1, FYN, LINGO1, SEMA4B]
GO:0030224;monocyte differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;69.52661413212034;7.004484905440688;0.0023269932051117304;0.6813299963962409;[MEF2C, JUN]
GO:0051569;regulation of histone H3-K4 methylation;10.0;0.8259837884571596;0.8282329060895002;9.523163736834295;104.17724647803128;6.518977089658987;0.003486718686184865;0.7486218033895181;[GATA3, MYB]
GO:0010694;positive regulation of alkaline phosphatase activity;10.0;1.0;0.9152410118609203;9.628524252492122;315.71736046966464;7.9853141584524145;0.01056677592774235;0.8236103492792612;[MEF2C]
GO:0014898;cardiac muscle hypertrophy in response to stress;7.0;1.0;0.8509193652572005;9.628524252492122;75.67165931027915;7.138016298065211;0.002532662337043095;0.7159578506919597;[MEF2C, EZH2]
GO:0051966;regulation of synaptic transmission, glutamatergic;7.0;0.811012628672052;0.7564256795932265;9.405380701177911;30.61939422688933;5.528578385631111;0.001024803569108247;0.6336511210035629;[MEF2C, NLGN1, LRRK2, GRIK3, PTGS2, KMO, GRM5, CNR1, TNR]
GO:0035115;embryonic forelimb morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;58.806290969860136;6.343086423195323;0.001968193636535348;0.647506047256038;[RUNX2, HOXA11]
GO:0030501;positive regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;171.85898464291293;6.221725566191056;0.005751965552953692;0.6690987000520388;[MEF2C, TGFB1, ADRB2, SLC8A1, LTF]
GO:0051963;regulation of synapse assembly;6.0;0.7090535922965819;0.6776471087384355;9.0306872517365;59.898395703774696;5.322726331426962;0.002004745399149018;0.5953247847114072;[ROBO2, NLGN1, AMIGO3, FLRT2, SLITRK6, EPHB1, GHSR, MEF2C, LRRN3, PTK2, TLR2]
GO:2000553;positive regulation of T-helper 2 cell cytokine production;10.0;1.0;0.9152410118609203;9.628524252492122;874.8811381751227;7.9853141584524145;0.029281484352815565;0.8236103492792612;[NLRP3, XCL1, GATA3]
GO:0014033;neural crest cell differentiation;5.0;0.8653626801206646;0.7229223519212526;9.271849308553389;46.51447820026907;7.9853141584524145;0.001556797725050427;0.6986103492792611;[MEF2C]
GO:0061085;regulation of histone H3-K27 methylation;10.0;0.8259837884571596;0.8282329060895002;9.523163736834295;104.17724647803128;7.57984905034425;0.003486718686184865;0.8028748447945538;[GATA3]
GO:0030182;neuron differentiation;4.0;0.5833093054345528;0.5416546527172764;7.212610474191073;21.066225782797595;4.296434704338478;7.050676185779127E-4;0.4697198705845162;[MEF2C, RUNX2, JAG1, BCL11B, FZD5, INHBA, USH2A, NR4A2, ITM2C]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[IFNA5, IFNA4, IFNA7, MEF2C, CR2, IFNA14, IFNA16, IFNA2, CD180, IFNA8, HSPD1, CD79A, CD40LG, PTPRC, MS4A1, CARD11, IFNA21, IFNA10]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, C3AR1, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, NCKAP1L, ELANE, JUP, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, ITGAM, FCAR, ALAD, FCGR3B, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, TTR, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, TLR2, LILRA3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:1904706;negative regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.8833163751231;6.8867018697843045;0.0027070918088165762;0.7031056191423581;[CNN1, MEF2C, CDKN1A, MYOCD, TPM1]
GO:0002572;pro-T cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;23.263450360134797;9.777073627680469;7.786067478076512E-4;0.8231203125901445;[GATA3]
GO:2000727;positive regulation of cardiac muscle cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.4949928598676;667.9527156383532;6.8867018697843045;0.02235577627399952;0.7484268790654467;[MEF2C, MYOCD, TGFB1]
GO:0030217;T cell differentiation;6.0;0.657518819034173;0.651879722107231;8.679443697794976;65.04859315339479;5.132682728539097;0.00217711787291102;0.5856059460217904;[ITK, CD3G, PTPN22, CD3E, CD3D, CCR9, CCR6, ANXA1, FCER1G, RHOH, RUNX2, VAV1, ZAP70, CLEC4D, LCK, KIT, BLM, GATA3, NKX2-3, EGR1, TGFB1, BCL11B, FZD5, BMX, CD4, PTPRC, DNAJA3, CD28, GPR18, IL18R1]
GO:0071560;cellular response to transforming growth factor beta stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;5.788089581116195;0.003262744749111514;0.6191234829421188;[CX3CR1, EPB41L5, PDGFD, FYN, MEF2C, TGFB1, ARG1, CAV1, COL1A1, NOX4, XCL1]
GO:0045064;T-helper 2 cell differentiation;11.0;1.0;0.9324289523296623;9.628524252492122;473.70362526189734;8.67846133901236;0.01585443403193107;0.8762458687964789;[GATA3]
GO:2000607;negative regulation of cell proliferation involved in mesonephros development;8.0;0.9326813400603323;0.8413406700301662;9.57973408832269;385.1822985404169;9.777073627680469;0.012891704890584945;0.875;[GATA3]
GO:0030218;erythrocyte differentiation;5.0;0.8436909121759173;0.712086467948879;9.117698628726131;22.675663695230284;5.885253329569843;7.589340571069517E-4;0.5912131408273906;[GATA3, LYN, INHBA, KLF1, TGFBR3, KIT, ACIN1, TRIM10]
GO:0071442;positive regulation of histone H3-K14 acetylation;12.0;1.0;0.9481203125901445;9.628524252492122;1488.212472397538;8.390779266560578;0.049809132146875434;0.8772251544931927;[GATA3]
GO:0045582;positive regulation of T cell differentiation;9.0;0.7043150770688792;0.7483981637147287;9.320222892837606;861.1600055729926;5.395046993006588;0.0288222503928399;0.6721435792979885;[CD86, CD83, CD80, DUSP10, MYB, ANXA1, SYK, ZAP70, IFNG, IL1B, GATA3, NLRP3, NCKAP1L, CCL19, IL12RB1, TGFB1, EGR3, LILRB2, VNN1, BCL6]
GO:2001016;positive regulation of skeletal muscle cell differentiation;9.0;0.8653626801206646;0.8289219652406215;9.541512875502493;376.2972035421309;7.9853141584524145;0.01259432875705866;0.8046099625986299;[MEF2C]
GO:0035984;cellular response to trichostatin A;6.0;1.0;0.8231203125901445;9.628524252492122;367.2586666355552;8.390779266560578;0.012291817060950673;0.7522251544931926;[MEF2C, EZH2]
GO:2000683;regulation of cellular response to X-ray;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;23.691248258258653;9.083926447120524;7.929247584647443E-4;0.714552420951524;[GATA3]
GO:0032753;positive regulation of interleukin-4 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;6.686031174322154;0.0021737836760178982;0.665044257777226;[CD86, PRG2, GATA3, CD3E, CD40LG, CD28, NLRP3, PRKCQ, HAVCR2]
GO:0033600;negative regulation of mammary gland epithelial cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;170.73536782227262;8.390779266560578;0.005714359109156348;0.7800242071602487;[GATA3, BRCA2, PHB2]
GO:0060065;uterus development;4.0;1.0;0.75;9.628524252492122;49.86610466882393;7.138016298065211;0.0016689736466849693;0.6150384854347593;[HOXA10, MYOCD, TGFB2, GATA3, HOXA11]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[CHRM2, FMR1, TNF, PYCARD, STMN1, IFNA14, IFNA16, RNASE6, RNASE2, IFNA10, GATA3, NLRP3, IFNA21, HMGA1, AZU1, DEFA1, CXCL10, CXCL12, PTPRC, IFNA5, CREBZF, IFNA4, IFNA7, CXCL9, IFNA2, IFNA8, CHUK, IRAK3, MMP12, ACTA2, EEF1G, FGR, IFNG, PSMA2, TLR8, XCL1, TLR7, UNC93B1, CXCR4, SAMHD1, CCL8, CCL5, CCL4, CCL19, CCT5, CARD9, LILRB1, MAPK14]
GO:0090073;positive regulation of protein homodimerization activity;6.0;1.0;0.8231203125901445;9.628524252492122;47.416497719221994;7.57984905034425;0.0015869875065849188;0.710754145523778;[MEF2C]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[SKP2, ESCO2, SPARCL1, SDC2, SERPINA1, TIMP1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, PSMC6, PSMC2, NUCB1, TNC, MEN1, FBXW2, PSMD14, CUL5, IGFBP7, NAE1, WFS1, COPS5, CCDC22, UBE2M, LAMC1, LAMB1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[EHMT2, SLA2, MYB, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, PRDM16, ELANE, JUN, PKIG, EZH2, PAWR, PAX5, SIRT1, AES, MMP12, NR1H2, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, RFC1, RBBP8, E2F7, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, PCBP3, EGR1, BCL11A, XPO1, CD36, IL1B, CHCHD3, CCNE1, TGFB1, CBX4, CAV1, NR4A2, MXD1, MYOCD, IFNG, FBP1, MEIS2]
GO:2000617;positive regulation of histone H3-K9 acetylation;12.0;1.0;0.9481203125901445;9.628524252492122;1488.212472397538;7.8311634786251565;0.049809132146875434;0.8486063770733797;[GATA3]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[TNC, EEF1B2, ALAD, CLDN3, IL1B, CLDN7, S100A8, PSMD14, GATA3, CCL7, CNR1, FYN, GSN]
GO:2000734;negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation;9.0;1.0;0.896240625180289;9.628524252492122;682.7633492668087;9.777073627680469;0.022851474852839032;0.896240625180289;[GATA3]
GO:0048863;stem cell differentiation;4.0;0.7043150770688792;0.6021575385344395;8.242229891372231;21.066225782797595;5.734022359845919;7.050676185779127E-4;0.5432381701418294;[HHEX, EPCAM, HOXA7, MEF2C, TGFB2, ACE, RUNX2, PAX2, LIN28A, KIT, HOXB4]
GO:0071353;cellular response to interleukin-4;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;6.599019797332524;0.0027327542132076126;0.6605944919115335;[ARG1, GATA3, CORO1A, ALAD, IMPDH2, XCL1, MCM2]
GO:0072602;interleukin-4 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;7.9853141584524145;0.004587596526932657;0.8236103492792612;[GATA3]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, PYCARD, TCL1A, AKT1, CHUK, SIRT1, CHI3L1, XCL1, CCL13, CALCA, GATA3, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, CCL20, MAPK14, NFKB1, COL1A1]
GO:2000611;positive regulation of thyroid hormone generation;6.0;1.0;0.8231203125901445;9.628524252492122;244.57046509045236;8.67846133901236;0.008185553367448905;0.7669372290569613;[GATA3]
GO:0071599;otic vesicle development;5.0;1.0;0.7902410118609202;9.628524252492122;62.396419773654905;8.16763571524637;0.0020883520166922035;0.7079342821725234;[GATA3]
GO:0035457;cellular response to interferon-alpha;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;7.474488534686424;0.0027327542132076126;0.7053660038532718;[GATA3]
GO:0060297;regulation of sarcomere organization;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;165.46881499726612;7.8311634786251565;0.005538092325693202;0.7967266896635242;[MEF2C]
GO:0032461;positive regulation of protein oligomerization;7.0;0.8653626801206646;0.7836007053175329;9.5544162803384;141.07486917829812;6.599019797332524;0.004721648912258263;0.6883935445785896;[TCL1A, BIK]
GO:0035690;cellular response to drug;4.0;0.5629771490299041;0.531488574514952;7.020557509946895;41.90713853914268;4.145861845859104;0.0014025942129290189;0.462019567599527;[TFRC, FMR1, TNF, SLC8A1, IL18RAP, CDH1, MYB, MEF2C, KCNQ1, CFTR, BLM, ABCB4, FOXO1, PDGFD, EGR1, TGFB1, JUP, NFKB1, EZH2, LRRK2, TNFAIP3, PTPN22, PDE4B, MAP4K1, ANXA1, PPP1R12A, ARG1, SIRT1, PAX2, DNM2, IL1B, FBP1, PCNA, PTAFR, PTGS2, GNAI1, CCL7, FYN, RAD51, CD69]
GO:0045599;negative regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;5.948432231191374;0.0038363580074348307;0.6273234135236593;[TGFB1I1, GATA3, TNF, FOXO1, TGFB1, JAG1, SORT1, SIRT1]
GO:0031929;TOR signaling;6.0;0.8653626801206646;0.7558016526504768;9.377209824211215;26.42836680105094;6.518977089658987;8.845336528452411E-4;0.6565011041187423;[GATA3, AKT1, CARD11]
GO:0048469;cell maturation;3.0;0.6954798709641801;0.5458602480722345;8.242229891372231;25.22197897315013;4.886724499458715;8.441569379239579E-4;0.4480276307483924;[CDKN1A, BRCA2, ROPN1L, FBXO5, HOXA5, RUNX2, BTK, CFTR, GATA3, CCL19, FZD5, NR4A2, SLC26A8, PLP1, SLC26A3]
GO:0048468;cell development;3.0;0.5052934683962566;0.45076704678827284;6.510574346213882;28.41553699003407;3.2909128387363804;9.510424507334451E-4;0.36641774820622075;[AKT1, TNFSF11, MEF2C, CXADR, RUNX2, SFRP2, ABCB4, GATA3, GJC1, SFN, TSPAN2, NCKAP1L, LYN, JAG1, BCL11B, SDC1, ROBO2, GABRB1, KIT, ENG, TLR2, COL11A1, FLNA, DMD, JAM3, GSN, GABRA5, MLH1, SULF2, PLP1, FMR1, ARID4A, ARID4B, SLC8A1, CLEC5A, MEN1, MSH2, S100A8, MYH11, EIF2B3, TGFB2, TGFB1, CAV2, INHBA, LIN28A, PTPRC, BCL6, UQCRQ, LSR, TGFBR3, ACTA2, PALLD, DLL1, WASF3, SLC4A7, MEIS1, KLF5, CD9, PTPN6]
GO:0042487;regulation of odontogenesis of dentin-containing tooth;7.0;0.811012628672052;0.7564256795932265;9.34084218004034;47.77839987207684;7.138016298065211;0.0015991000459501783;0.7159578506919597;[RUNX2]
GO:0072160;nephron tubule epithelial cell differentiation;6.0;0.8653626801206646;0.7558016526504768;9.310070521373587;49.624654608214016;9.083926447120524;0.0016608925304473024;0.7876727335416686;[MEF2C]
GO:0045879;negative regulation of smoothened signaling pathway;7.0;0.8653626801206646;0.7836007053175329;9.446202695698167;188.1075192762445;6.444869117505266;0.006295789384399518;0.6805102716434839;[CD3E, RUNX2, PRKACB]
GO:0046449;creatinine metabolic process;6.0;0.8933024483968273;0.7697715367885581;9.5544162803384;104.72312179279828;8.390779266560578;0.0035049886417142283;0.7522251544931926;[GHR, MME]
GO:0030318;melanocyte differentiation;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;22.857985252022832;6.8867018697843045;7.650361955340501E-4;0.6424272657460779;[MEF2C, EDNRB, KIT]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD80, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, IL1B, ADAM9, TLR4, CX3CR1, CD274, CEBPE, KLRK1, STAP1, NLRP3, CCL2, ABCA1, CCL20, NR1H2, DEFA4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, PF4]
GO:2000987;positive regulation of behavioral fear response;7.0;1.0;0.8509193652572005;9.628524252492122;209.702758470375;8.16763571524637;0.007018562605773582;0.7686126355688037;[MEF2C]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[PHB2, AKT1, PROK2, MEF2C, CLDN7, PRKCQ, GATA3, SLC30A10, FIGNL1, SFN, NCKAP1L, BARD1, JUN, PLK2, AZU1, CDKN1A, CHL1, TIMP1, ANXA1, DUSP1, ANXA5, SERPINB9, SIRT1, PAX2, PTGS2, UNG, NTF3, FLNA, CCL19, GABRA5, PF4, TNF, CLEC5A, F2R, MSH2, BLM, CORO1A, FOXO1, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, CXCL12, COPS5, BCL6, MYD88, LRRK2, FASLG, TNFRSF1B, ADAMTS20, CX3CR1, LRP1, NLRC4, CCL5, CCL2, FYN, TIE1, IL2RB, SLC46A2, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB1, FLT3LG, MIF, BTC, POR, SFRP2, EPHA3, NAIP, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, CD28, NRP1, CTSH, CCR7, CCR5, FCER1G, HCK, CEACAM6, IL1B, KIT, GNAI2, CXCR2, PDPN, LILRB1, CD40LG, GRINA, COMP, ARHGDIA, PDGFRB, GHSR, C5AR1, PSEN2, CBX4, CAV1, NR4A2, NFKBIA, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, MMP9, NDUFS3, LTF, BCL2A1, TAF9, DLL1, THBS1, HSPD1, TEK]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, SLA2, LGALS3, TRBC1, RNASE6, RNASE3, MIF, SLPI, BTK, PADI4, TRIM10, NAIP, GATA3, LY9, KLRK1, SLAMF7, IGHA1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, PTK2, MARCO, VNN1, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QA, LILRA5, IGKC, CARD9, KIR3DL1, LGR4, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, CLEC4D, S100A8, IFNA10, BLK, LY96, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, DEFA1, BMX, NFKB1, LCN2, KLRD1, ITGAM, KIR3DS1, CRISP3, HMGB2, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, FGR, ZAP70, LCK, LTF, COLEC12, UNC93B1, HIST1H2BK, NLRC4, FYN, CSK, CD6, PTX3, PTPN6, CD244]
GO:0071864;positive regulation of cell proliferation in bone marrow;6.0;1.0;0.8231203125901445;9.628524252492122;63.05258358394898;7.9853141584524145;0.0021103132289136558;0.7314896500084853;[MEF2C, FLT3LG]
GO:0071345;cellular response to cytokine stimulus;5.0;0.6729672293956388;0.6267246265587396;8.214830917184116;61.59823360834823;3.805811787890007;0.0020616374440603005;0.48487040368196277;[PID1, TFRC, TCL1A, AKT1, TNFSF11, BTK, PADI2, STXBP2, GATA3, ADAMTS12, ST3GAL6, EGR1, COL1A1, CCR7, HLA-DPA1, MME, ARG1, SIRT1, TLR4, TLR2, CCL13, CXCR4, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL20, NLRP12, ZYX, IL18R1, IL17A, PYCARD, TLE4, KMO, KIF16B, CALCA, CSF2RB, CORO1A, NFKB1, BSPRY, ALAD, CHUK, CHI3L1, XCL1, MCM2, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, MAPK14, CD4, KLF5, IMPDH2, PTPN6, RBMX]
GO:0072676;lymphocyte migration;6.0;0.6763753087927167;0.6613079669865028;8.663443356448536;29.137022145890857;5.666199763507158;9.751899096054872E-4;0.6128900320011365;[CCL13, CXCL9, GATA3, CXCL13, CXCL16, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CCR7, CCR6, CCL19, CCL18, CCR2, CCL23, GPR15, CCL20, DEFA1, CXCL10, ZAP70, CXCL11, XCL1]
GO:0032332;positive regulation of chondrocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.567899630675686;229.711107350086;6.832634648514029;0.007688224036432589;0.7003406189322132;[POR, RUNX2, HOXA11]
GO:0030279;negative regulation of ossification;5.0;0.8436909121759173;0.712086467948879;9.377209824211215;41.83246312675316;5.500407508664414;0.0014000948940798496;0.571532107649126;[CALCA, TNF, MEN1, CCR1, MEF2C, TGFB1, TMEM64, AXIN2]
GO:0071902;positive regulation of protein serine/threonine kinase activity;11.0;0.6763753087927167;0.7706166067260205;9.206529842432747;1260.5827351979337;3.9422628906178643;0.04219056969626795;0.6340364598898325;[, CCNH, TCL1A, AKT1, PROK2, TNFSF11, ACSL1, MIF, FPR1, TGFA, IQGAP3, PDGFD, PDGFC, ELANE, FZD5, CDC6, NOX4, CD24, EZH2, MAP4K1, SYK, SIRT1, DUSP6, MDFIC, IL1B, KIT, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CD40LG, PKN1, CCNT2, TNF, PDGFRB, MAP2K2, F2R, ADAM9, C5AR1, TNFRSF11A, ADRB2, DRD4, MAP2K6, TGFB1, GH1, CSPG4, LRRK2, GHR, PSRC1, IFNG, PDE5A, LTF, THBS1, CSK, EGF, MAPK14]
